Cancer incidence in a kidney-transplanted population.

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMID 11112040)

Published in Transpl Int on January 01, 2000

Authors

L Kyllönen1, K Salmela, E Pukkala

Author Affiliations

1: Department of Surgery, Helsinki University Central Hospital, Finland.

Articles citing this

Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99

Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64

Glucocorticoid therapy and risk of bladder cancer. Br J Cancer (2009) 1.19

Cancer in the transplant recipient. Cold Spring Harb Perspect Med (2013) 1.06

Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers? J Natl Cancer Inst (2009) 0.94

Importance of pre-transplant colonoscopy in renal transplant recipients. J Clin Med Res (2014) 0.91

Risk of bladder cancer in renal transplant recipients: a meta-analysis. Br J Cancer (2014) 0.90

Cancer Metastases: Early Dissemination and Late Recurrences. Cancer Growth Metastasis (2015) 0.86

Risk of Colorectal Cancer After Solid Organ Transplantation in the United States. Am J Transplant (2016) 0.79

Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database. PLoS One (2016) 0.78

Onco-nephrology: an appraisal of the cancer and chronic kidney disease links. Nephrol Dial Transplant (2015) 0.78

High-grade urothelial carcinoma in a kidney transplant recipient with BK virus infection. NDT Plus (2009) 0.78

Cancer incidence in kidney transplant recipients: a study protocol. BMC Cancer (2009) 0.78

Treatment of advanced rectal cancer in a patient after combined pancreas-kidney transplantation. Langenbecks Arch Surg (2003) 0.78

Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies. Mol Clin Oncol (2016) 0.75

Sonographically Unusual Breast Carcinomas, 2 Case Reports. Pol J Radiol (2016) 0.75

Articles by these authors

(truncated to the top 100)

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49

Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (2001) 6.23

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99

Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol (1994) 4.89

Current status of clinical islet transplantation. Transplantation (2005) 4.17

Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A (2001) 3.31

Coeliac disease--associated disorders and survival. Gut (1994) 3.13

Aggressiveness of screen-detected breast cancers. Lancet (1995) 3.07

Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83

Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet (2002) 2.76

Scandiatransplant: thirty years of cooperation in organ transplantation in the Nordic countries. Clin Transpl (1998) 2.73

Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67

Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ (1997) 2.41

Social class as a prognostic factor in breast cancer survival. Cancer (1990) 2.37

Risk of cancer in Finnish children living close to power lines. BMJ (1993) 2.29

Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology (2000) 2.25

Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry (2001) 2.23

Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09

From cross-tabulations to multipurpose exposure information systems: a new job-exposure matrix. Am J Ind Med (1998) 2.07

Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07

Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06

Progression of asbestosis predicts lung cancer. Chest (1998) 2.02

Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96

Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst (1996) 1.93

Multiple cancer--an epidemiologic exercise in Finland. J Natl Cancer Inst (1985) 1.87

Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect (1999) 1.84

Work-related cancer in the Nordic countries. Scand J Work Environ Health (1999) 1.84

Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol (1999) 1.84

Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol (1995) 1.84

Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol (1999) 1.83

Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol (2000) 1.71

Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect (2007) 1.69

Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut (2008) 1.64

Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med (1999) 1.63

Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet (2005) 1.61

Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl (1986) 1.60

Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer (2000) 1.59

Jejunal diverticulosis: a potentially dangerous entity. Scand J Gastroenterol (2004) 1.59

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58

Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol (1993) 1.58

Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol (1996) 1.58

Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med (1995) 1.56

Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer (1999) 1.56

Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol (1997) 1.56

Magnetic fields of high voltage power lines and risk of cancer in Finnish adults: nationwide cohort study. BMJ (1996) 1.55

Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55

Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst (2000) 1.54

Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res (2003) 1.54

Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer (1995) 1.52

Selective screening: theory and practice based on high-risk groups of cervical cancer. J Epidemiol Community Health (1979) 1.48

Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol (2001) 1.46

Current characteristics and outcome of cytomegalovirus infections after kidney transplantation. Transpl Infect Dis (2014) 1.46

Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen (1999) 1.45

Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia (1998) 1.44

Pharmacokinetics of propofol and haemodynamic changes during induction of anaesthesia in uraemic patients. Br J Anaesth (1992) 1.40

Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Br J Dermatol (2012) 1.40

Stability over time of serum antibody levels to human papillomavirus type 16. J Infect Dis (1998) 1.39

Incidence and mortality from breast cancer in the Mama Program for Breast Screening in Finland, 1973-1986. Cancer (1994) 1.38

A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev (1994) 1.36

Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis (2006) 1.35

Dietary antioxidants and the risk of lung cancer. Am J Epidemiol (1991) 1.32

Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Br J Cancer (1998) 1.31

Breast cancer risk among Finnish cabin attendants: a nested case-control study. Occup Environ Med (2005) 1.27

Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer (2009) 1.26

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland. Br J Cancer (2007) 1.25

Social class and cancer patient survival in Finland. Am J Epidemiol (1995) 1.24

A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis (2001) 1.22

Education, survival and avoidable deaths in cancer patients in Finland. Br J Cancer (2010) 1.21

Leanness and lung-cancer risk. Int J Cancer (1991) 1.21

Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia (2007) 1.21

Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis (1992) 1.20

Dietary fat and risk of breast cancer. Am J Clin Nutr (1990) 1.20

Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976-1995. Int J Cancer (1999) 1.20

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer (2002) 1.20

The Estonian study of Chernobyl cleanup workers: II. Incidence of cancer and mortality. Radiat Res (1997) 1.20

Drinking water mutagenicity and gastrointestinal and urinary tract cancers: an ecological study in Finland. Am J Public Health (1994) 1.18

Selective screening for cervical cancer. Experience of the Finnish mass screening system. Br J Prev Soc Med (1977) 1.18

Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control (1997) 1.18

Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin Orthop Relat Res (1996) 1.16

A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. Clin Cancer Res (2000) 1.16

Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect (2001) 1.16

Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland. Int J Cancer (2001) 1.15

Drinking water chlorination and cancer-a historical cohort study in Finland. Cancer Causes Control (1997) 1.15

Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol (2000) 1.15

Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia (2005) 1.13

Cancer incidence following chlorophenol exposure in a community in southern Finland. Arch Environ Health (1992) 1.13

A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients. Transplantation (2001) 1.09

Primary CMV infections are common in kidney transplant recipients after 6 months valganciclovir prophylaxis. Am J Transplant (2010) 1.08

Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995. Int J Cancer (2000) 1.06

Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer (1999) 1.06

Risk of a new primary cancer among patients with lung cancer of different histological types. Eur J Cancer (2001) 1.05

Cosmic radiation and cancer mortality among airline pilots: results from a European cohort study (ESCAPE). Radiat Environ Biophys (2003) 1.05

Incidence of cancer among welders, platers, machinists, and pipe fitters in shipyards and machine shops. Br J Ind Med (1988) 1.05

Population density and childhood leukaemia: results of the EUROCLUS Study. Eur J Cancer (1999) 1.04

Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer (1996) 1.04

Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer (2005) 1.04

Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer (1996) 1.03

Incidence of leukaemia and brain tumours in Finnish workers exposed to ELF magnetic fields. Int Arch Occup Environ Health (1990) 1.03